DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells

References

• Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6:463 - 77; http://dx.doi.org/10.1016/S1534-5807(04)00099-1; PMID: 15068787
   PubMed Web of Science ®Google Scholar
• Klionsky DJ. The molecular machinery of autophagy: unanswered questions. J Cell Sci 2005; 118:7 - 18; http://dx.doi.org/10.1242/jcs.01620; PMID: 15615779
   PubMed Web of Science ®Google Scholar
• Bray K, Mathew R, Lau A, Kamphorst JJ, Fan J, Chen J, Chen HY, Ghavami A, Stein M, DiPaola RS, et al. Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS One 2012; 7:e41831; http://dx.doi.org/10.1371/journal.pone.0041831; PMID: 22848625
   PubMed Web of Science ®Google Scholar
• Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ 2005; 12:Suppl 2 1542 - 52; http://dx.doi.org/10.1038/sj.cdd.4401765; PMID: 16247502
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe T, et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 2009; 11:385 - 96; http://dx.doi.org/10.1038/ncb1846; PMID: 19270696
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981 - 91; http://dx.doi.org/10.1091/mbc.E08-12-1248; PMID: 19211835
   PubMed Web of Science ®Google Scholar
• He C, Levine B. The Beclin 1 interactome. Curr Opin Cell Biol 2010; 22:140 - 9; http://dx.doi.org/10.1016/j.ceb.2010.01.001; PMID: 20097051
   PubMed Web of Science ®Google Scholar
• Sun Q, Fan W, Chen K, Ding X, Chen S, Zhong Q. Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 2008; 105:19211 - 6; http://dx.doi.org/10.1073/pnas.0810452105; PMID: 19050071
   PubMed Web of Science ®Google Scholar
• Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 2008; 19:5360 - 72; http://dx.doi.org/10.1091/mbc.E08-01-0080; PMID: 18843052
   PubMed Web of Science ®Google Scholar
• Wu X, Liang L, Dong L, Yu Z, Fu X. Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro. Mol Biol Rep 2013; 40:2671 - 8; http://dx.doi.org/10.1007/s11033-012-2353-x; PMID: 23247805
   PubMed Web of Science ®Google Scholar
• Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A 1999; 96:214 - 9; http://dx.doi.org/10.1073/pnas.96.1.214; PMID: 9874798
   PubMed Web of Science ®Google Scholar
• Dalai I, Missiaglia E, Barbi S, Butturini G, Doglioni C, Falconi M, Scarpa A. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. Neoplasia 2007; 9:181 - 3; http://dx.doi.org/10.1593/neo.06838; PMID: 17401457
   PubMed Web of Science ®Google Scholar
• Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y, Liu J, Bast RC Jr.. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res 2004; 10:6559 - 66; http://dx.doi.org/10.1158/1078-0432.CCR-04-0698; PMID: 15475444
   PubMed Web of Science ®Google Scholar
• Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC Jr., et al. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res 2003; 9:3660 - 6; PMID: 14506155
   PubMed Web of Science ®Google Scholar
• Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008; 112:1489 - 502; http://dx.doi.org/10.1002/cncr.23323; PMID: 18286529
   PubMed Web of Science ®Google Scholar
• Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, et al. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 2007; 9:R57; http://dx.doi.org/10.1186/bcr1762; PMID: 17764565
   PubMed Web of Science ®Google Scholar
• Fujii S, Luo RZ, Yuan J, Kadota M, Oshimura M, Dent SR, Kondo Y, Issa JP, Bast RC Jr., Yu Y. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet 2003; 12:1791 - 800; http://dx.doi.org/10.1093/hmg/ddg204; PMID: 12874100
   PubMed Web of Science ®Google Scholar
• Hisatomi H, Nagao K, Wakita K, Kohno N. ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology 2002; 62:136 - 40; http://dx.doi.org/10.1159/000048259; PMID: 11914599
   PubMed Web of Science ®Google Scholar
• Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota M, Oshimura M, Dent SR, Issa JP, et al. Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann N Y Acad Sci 2003; 983:268 - 77; http://dx.doi.org/10.1111/j.1749-6632.2003.tb05981.x; PMID: 12724231
   PubMed Web of Science ®Google Scholar
• Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, et al. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 2003; 63:4174 - 80; PMID: 12874023
   PubMed Web of Science ®Google Scholar
• Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C, Huang M, Nishmoto A, Liu J, Liao WS, et al. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res 2006; 12:2404 - 13; http://dx.doi.org/10.1158/1078-0432.CCR-05-1036; PMID: 16638845
   PubMed Web of Science ®Google Scholar
• Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118:3917 - 29; PMID: 19033662
   PubMed Web of Science ®Google Scholar
• Kueck A, Opipari AW Jr., Griffith KA, Tan L, Choi M, Huang J, Wahl H, Liu JR. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 2007; 107:450 - 7; http://dx.doi.org/10.1016/j.ygyno.2007.07.065; PMID: 17825886
   PubMed Web of Science ®Google Scholar
• Bjørkøy G, Lamark T, Pankiv S, Øvervatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 2009; 452:181 - 97; http://dx.doi.org/10.1016/S0076-6879(08)03612-4; PMID: 19200883
   PubMed Web of Science ®Google Scholar
• Walczak M, Martens S. Dissecting the role of the Atg12-Atg5-Atg16 complex during autophagosome formation. Autophagy 2013; 9:424 - 5; http://dx.doi.org/10.4161/auto.22931; PMID: 23321721
   PubMed Web of Science ®Google Scholar
• Matsushita M, Suzuki NN, Obara K, Fujioka Y, Ohsumi Y, Inagaki F. Structure of Atg5.Atg16, a complex essential for autophagy. J Biol Chem 2007; 282:6763 - 72; http://dx.doi.org/10.1074/jbc.M609876200; PMID: 17192262
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:1992 - 2003; http://dx.doi.org/10.1091/mbc.E08-12-1249; PMID: 19225151
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam H, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009; 284:12297 - 305; http://dx.doi.org/10.1074/jbc.M900573200; PMID: 19258318
   PubMed Web of Science ®Google Scholar
• Bodemann BO, Orvedahl A, Cheng T, Ram RR, Ou YH, Formstecher E, Maiti M, Hazelett CC, Wauson EM, Balakireva M, et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011; 144:253 - 67; http://dx.doi.org/10.1016/j.cell.2010.12.018; PMID: 21241894
   PubMed Web of Science ®Google Scholar
• Tanida I. Autophagy basics. Microbiol Immunol 2011; 55:1 - 11; http://dx.doi.org/10.1111/j.1348-0421.2010.00271.x; PMID: 21175768
   PubMed Web of Science ®Google Scholar
• Tanida I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal 2011; 14:2201 - 14; http://dx.doi.org/10.1089/ars.2010.3482; PMID: 20712405
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T, Ohsumi Y. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 2001; 20:5971 - 81; http://dx.doi.org/10.1093/emboj/20.21.5971; PMID: 11689437
   PubMed Web of Science ®Google Scholar
• Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R, Corazzari M, Fuoco C, Ucar A, Schwartz P, et al. Ambra1 regulates autophagy and development of the nervous system. Nature 2007; 447:1121 - 5; PMID: 17589504
   PubMed Web of Science ®Google Scholar
• Cecconi F, Levine B. The role of autophagy in mammalian development: cell makeover rather than cell death. Dev Cell 2008; 15:344 - 57; http://dx.doi.org/10.1016/j.devcel.2008.08.012; PMID: 18804433
   PubMed Web of Science ®Google Scholar
• Ku B, Woo JS, Liang C, Lee KH, Jung JU, Oh BH. An insight into the mechanistic role of Beclin 1 and its inhibition by prosurvival Bcl-2 family proteins. Autophagy 2008; 4:519 - 20; PMID: 18334862
   PubMed Web of Science ®Google Scholar
• Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res 2007; 17:839 - 49; http://dx.doi.org/10.1038/cr.2007.78; PMID: 17893711
   PubMed Web of Science ®Google Scholar
• Furuya N, Yu J, Byfield M, Pattingre S, Levine B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 2005; 1:46 - 52; http://dx.doi.org/10.4161/auto.1.1.1542; PMID: 16874027
   PubMed Web of Science ®Google Scholar
• Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 2003; 22:2897 - 909; http://dx.doi.org/10.1038/sj.onc.1206380; PMID: 12771940
   PubMed Web of Science ®Google Scholar
• Luo RZ, Peng H, Xu F, Bao J, Pang Y, Pershad R, Issa JP, Liao WS, Bast RC Jr., Yu Y. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta 2001; 1519:216 - 22; http://dx.doi.org/10.1016/S0167-4781(01)00226-3; PMID: 11418188
   PubMed Web of Science ®Google Scholar
• Itakura E, Mizushima N. Atg14 and UVRAG: mutually exclusive subunits of mammalian Beclin 1-PI3K complexes. Autophagy 2009; 5:534 - 6; http://dx.doi.org/10.4161/auto.5.4.8062; PMID: 19223761
   PubMed Web of Science ®Google Scholar
• Vergne I, Roberts E, Elmaoued RA, Tosch V, Delgado MA, Proikas-Cezanne T, Laporte J, Deretic V. Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J 2009; 28:2244 - 58; http://dx.doi.org/10.1038/emboj.2009.159; PMID: 19590496
   PubMed Web of Science ®Google Scholar
• Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 2006; 119:259 - 70; http://dx.doi.org/10.1242/jcs.02735; PMID: 16390869
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Noda T, Yoshimori T. Binding Rubicon to cross the Rubicon. Autophagy 2009; 5:876 - 7; PMID: 19550146
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe T, et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 2009; 11:385 - 96; http://dx.doi.org/10.1038/ncb1846; PMID: 19270696
   PubMed Web of Science ®Google Scholar
• Wei Y, Sinha S, Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 2008; 4:949 - 51; PMID: 18769111
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, Geneste O, Kroemer G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007; 3:374 - 6; PMID: 17438366
   PubMed Web of Science ®Google Scholar
• Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, Joza N, Vitale I, Morselli E, Tailler M, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ 2009; 16:1006 - 17; http://dx.doi.org/10.1038/cdd.2009.34; PMID: 19325567
   PubMed Web of Science ®Google Scholar
• Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008; 283:33175 - 82; http://dx.doi.org/10.1074/jbc.M804478200; PMID: 18772134
   PubMed Web of Science ®Google Scholar
• Noble CG, Dong JM, Manser E, Song H. Bcl-xL and UVRAG cause a monomer-dimer switch in Beclin1. J Biol Chem 2008; 283:26274 - 82; http://dx.doi.org/10.1074/jbc.M804723200; PMID: 18641390
   PubMed Web of Science ®Google Scholar
• Li X, He L, Che KH, Funderburk SF, Pan L, Pan N, Zhang M, Yue Z, Zhao Y. Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and heterodimer formation with Atg14L and UVRAG. Nat Commun 2012; 3:662; http://dx.doi.org/10.1038/ncomms1648; PMID: 22314358
   PubMed Web of Science ®Google Scholar
• Kroep JR, Nortier JW. The role of bevacizumab in advanced epithelial ovarian cancer. Curr Pharm Des 2012; 18:3775 - 83; http://dx.doi.org/10.2174/138161212802002689; PMID: 22591420
   PubMed Web of Science ®Google Scholar
• Aggarwal C, Somaiah N, Simon G. Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed?. Cancer Biol Ther 2012; 13:247 - 63; http://dx.doi.org/10.4161/cbt.19594; PMID: 22481432
   PubMed Web of Science ®Google Scholar
• Sato S, Itamochi H. Bevacizumab and ovarian cancer. Curr Opin Obstet Gynecol 2012; 24:8 - 13; http://dx.doi.org/10.1097/GCO.0b013e32834daeed; PMID: 22123222
   PubMed Web of Science ®Google Scholar
• Tol J, Punt CJ. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Clin Ther 2010; 32:437 - 53; http://dx.doi.org/10.1016/j.clinthera.2010.03.012; PMID: 20399983
   PubMed Web of Science ®Google Scholar
• Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK, Bao JJ, Das P, Andreeff M, Chen W, et al. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. . Oncogene . 2012; ; . 31::. 68 - -. 79; http://dx.doi.org/10.1038/onc.2011.213; PMID: 21643014
   PubMed Web of Science ®Google Scholar
• Klockenbusch C, Kast J. Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1. J Biomed Biotechnol 2010; 2010:927585; http://dx.doi.org/10.1155/2010/927585; PMID: 20634879
   PubMed Web of Science ®Google Scholar